SMTL ID : 5wdj.1

CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-6 AKA 7-(BENZYLOXY)-1H-[1,2, 3]TRIAZOLO[4,5-D]PYRIMIDIN-5-AMINE

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.40 Å
Oligo State
hetero-2-2-mer
Ligands
1 x NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
2 x AEY: 7-(benzyloxy)-1H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine(Non-covalent)
4 x CL: CHLORIDE ION(Non-functional Binders)
2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
2 x CA: CALCIUM ION(Non-covalent)
5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
2 x FUC: alpha-L-fucopyranose(Non-covalent)
3 x MAN: alpha-D-mannopyranose(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Duclos, F. et al., Triazolopyrimidines identified as reversible myeloperoxidase inhibitors. Medchemcomm (2017)
Release Date
2018-04-18
Peptides
Myeloperoxidase: AC
Myeloperoxidase: BD
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
C
D
B
B
D
E

Myeloperoxidase

Myeloperoxidase

Related Entries With Identical Sequence

5fiw.1 | 5fiw.2 | 5qj2.1 | 5qj2.2 | 5qj2.3 | 5qj2.4 | 5qj3.1 | 5qj3.2 | 6wxz.1 | 6wxz.2 | 6wy0.1 | 6wy0.2 | 6wy0.3 | 6wy0.4 | 6wy5.1 | 6wy5.2 | 6wy7.1 | 6wy7.2 | 6wyd.1 | 6wyd.2 | 6wyd.3 | 6wyd.4 | 7lae.1 | 7lae.2 | 7lag.1 | 7lag.2 | 7lag.3 | 7lag.4 | 7lal.1 | 7lal.2  more...